The effects of bioactive akermanite on physiochemical, drug-delivery, and biological properties of poly(lactide-co-glycolide) beads

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 96 B, Issue 2, 2011, Pages 360-368

  Liu, Gang ^a   Wu, Chengtie ^a   Fan, Wei ^a   Miao, Xigeng ^a   Sin, Dong Choon ^a   Crawford, Ross ^a   Xiao, Yin ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

beads; bioactive akermanite; cell differentiation; drug delivery; poly(lactide co glycolide)

Indexed keywords

ACIDIC DEGRADATION; AKERMANITE; ALKALINE PHOSPHATASE ACTIVITY; BEADS; BIOACTIVE CERAMIC; BIOACTIVE DRUGS; BIOLOGICAL ENVIRONMENTS; BIOLOGICAL PROPERTIES; BONE MARROW STROMAL CELLS; BONE TISSUE; BOVINE SERUM ALBUMINS; CELL DIFFERENTIATION; COMPOSITE BEADS; CONTROLLABLE RELEASE; IN-VIVO; MECHANICAL STRENGTH; MICRO-POROUS STRUCTURE; PH VALUE; PHYSIO-CHEMICAL; POLY LACTIDE-CO-GLYCOLIDE; SEM; SIMULATED BODY FLUIDS;

APATITE; BODY FLUIDS; BONE; COMPRESSIVE STRENGTH; DEGRADATION; DRUG DELIVERY; PHOSPHATASES; PHOSPHATE MINERALS;

DRUG PRODUCTS;

AKERMANITE; ALKALINE PHOSPHATASE; APATITE; BIOCERAMICS; BOVINE SERUM ALBUMIN; NANOBEAD; POLYGLACTIN; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADATION; BONE MARROW CELL; BONE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DIFFERENTIATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PH; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY;

ANIMALS; BODY FLUIDS; BONE AND BONES; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CERAMICS; DENTAL MATERIALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; MECHANICAL PHENOMENA; MICROSPHERES; POLYGLYCOLIC ACID; REGENERATION; SERUM ALBUMIN, BOVINE; STROMAL CELLS;

EID: 78651094473     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31779     Document Type: Article

References (34)

1. Li X, Zhang Y, Yan R, Jia W, Yuan M, Deng X, Huang Z,. Influence of process parameters on the protein stability encapsulated in poly- DL -lactide-poly(ethylene glycol) microspheres. J Control Release 2000; 68: 41-52.
2. Wang G, Siggers K, Zhang S, Jiang H, Xu Z, Zernicke RF, Matyas J, Uludag H,. Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res 2008; 25: 2896-2909.
3. Mondal N, Pal TK, Ghosal SK,. Development, physical characterization, micromeritics and in vitro release kinetics of letrozole loaded biodegradable nanoparticles. Pharmazie 2008; 63: 361-365.
4. Teixeira M, Alonso MJ, Pinto MM, Barbosa CM,. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm 2005; 59: 491-500.
5. Cleland JL, Mac A, Boyd B, Yang J, Duenas ET, Yeung D, Brooks D, Hsu C, Chu H, Mukku V, Jones AJ,. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 1997; 14: 420-425. (Pubitemid 27204998)
6. Verrier S, Blaker JJ, Maquet V, Hench LL, Boccaccini AR,. PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: An in vitro cell biology assessment. Biomaterials 2004; 25: 3013-3021.
7. Ara M, Watanabe M, Imai Y,. Effect of blending calcium compounds on hydrolytic degradation of poly(DL -lactic acid-co-glycolic acid). Biomaterials 2002; 23: 2479-2483.
8. Heidemann W, Jeschkeit-Schubbert S, Ruffieux K, Fischer JH, Jung H, Krueger G, Wintermantel E, Gerlach KL,. pH-stabilization of predegraded PDLLA by an admixture of water-soluble sodiumhydrogenphosphate-Results of an in vitro- and in vivo study. Biomaterials 2002; 23: 3567-3574.
9. Brunner A, Mader K, Gopferich A,. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm Res 1999; 16: 847-853.
10. Zolnik BS, Burgess DJ,. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release 2007; 122: 338-344.
11. Jeyanthi R, Thanoo BC, Metha RC, DeLuca PP,. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J Control Release 1996; 38: 235-244.
12. Kim TK, Yoon JJ, Lee DS, Park TG,. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials 2006; 27: 152-159.
13. Crotts G, Park TG,. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Release 1995; 35: 91-105.
14. Hong Y, Gao CY, Shi YC, Shen JC,. Preparation of porous polylactide microspheres by emulsion-solvent evaporation based on solution induced phase separation. Polym Adv Tech 2005; 16: 622-627.
15. Bittner B, Morlock M, Koll H, Winter G, Kissel T,. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: Influence of the encapsulation technique and polymer purity on microsphere characteristics. Eur J Pharm Biopharm 1998; 45: 295-305.
16. Keshaw H, Thapar N, Burns AJ, Mordan N, Knowles JC, Forbes A, Day RM,. Microporous collagen spheres produced via thermally induced phase separation for tissue regeneration. Acta Biomater 2010; 6: 1158-1166.
17. Johnson OL, Jaworowicz W, Cleland JL, Bailey L, Charnis M, Duenas E, Wu C, Shepard D, Magil S, Last T, Jones AJ, Putney SD,. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res 1997; 14: 730-735. (Pubitemid 27281666)
18. Nam YS, Park TG,. Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. J Biomed Mater Res 1999; 47: 8-17.
19. Wu C, Chang J,. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. J Biomed Mater Res B Appl Biomater 2007; 83: 153-160.
20. Wu C, Chang J,. A novel akermanite bioceramic: Preparation and characteristics. J Biomater Appl 2006; 21: 119-129. (Pubitemid 44848511)
21. Wu C, Chang J, Zhai W, Ni S, Wang J,. Porous akermanite scaffolds for bone tissue engineering: Preparation, characterization, and in vitro studies. J Biomed Mater Res B Appl Biomater 2006; 78: 47-55.
22. Huang Y, Jin X, Zhang X, Sun H, Tu J, Tang T, Chang J, Dai K,. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 2009; 30: 5041-5048.
23. Wu C, Chang J, Ni S, Wang J,. In vitro bioactivity of akermanite ceramics. J Biomed Mater Res A 2006; 76: 73-80.
24. Dittrich M, Hampl J, Soukup F,. Branched oligoester microspheres fabricated by a rapid emulsion solvent extraction method. J Microencapsul 2000; 17: 587-598.
25. Kokubo T, Ito S, Huang ZT, Hayashi T, Sakka S, Kitsugi T, Yamamuro T,. Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res 1990; 24: 331-343.
26. Wu C, Zhang Y, Zhu Y, Friis T, Xiao Y,. Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials 2010; 31: 3429-3438.
27. Shi X, Wang Y, Ren L, Huang W, Wang DA,. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications. Int J Pharm 2009; 373: 85-92.
28. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jerome R,. Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I. Preparation and in vitro characterisation. Biomaterials 2004; 25: 4185-4194.
29. Hench L,. Bioceramics. J Am Ceram Soc 1998; 81: 1705-1728.
30. Fu K, Pack DW, Klibanov AM, Langer R,. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res 2000; 17: 100-106.
31. Juin P, Pelletier M, Oliver L, Tremblais K, Gregoire M, Meflah K, Vallette FM,. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 1998; 273: 17559-17564.
32. Zreiqat H, Howlett CR, Zannettino A, Evans P, Schulze-Tanzil G, Knabe C, Shakibaei M,. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 2002; 62: 175-184.
33. Valerio P, Pereira MM, Goes AM, Leite MF,. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004; 25: 2941-2948.
34. Silver IA, Deas J, Erecinska M,. Interactions of bioactive glasses with osteoblasts in vitro: Effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. Biomaterials 2001; 22: 175-185.